MorphoSys AG: Patents

View up-to-date information on MorphoSys AG patents, including inventor and filing insights.

Patent Trends

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
CN115054697A	Application	抗-CD19抗体和磷酸肌醇3-激酶抑制剂的组合及其用途	A61K2300/00; A61K31/505; A61K31/519; A61K39/395; A61K39/39558; A61P35/02; C07D403/12; C07D473/16; C07K16/2803; C07K2317/565; C07K2317/73	September 16, 2022
WO2022184676A1	Application	ANTI-CD38 ANTIBODIES FOR USE IN THE TREATMENT OF ANTIBODY-MEDIATED TRANSPLANT REJECTION	A61K2039/505; A61K2039/545; A61P37/06; C07K16/2896; C07K2317/21	September 09, 2022
CN115028617A	Application	CBP/EP300的杂环抑制剂及其在治疗癌症中的用途	A61K31/435; A61K31/437; A61K31/4375; A61K31/496; A61K31/4985; A61K31/5025; A61K31/519; A61K31/5377; A61K31/5513; A61K45/06; A61P29/00; A61P35/00; A61P35/02; A61P37/06; C07D243/14; C07D267/14; C07D401/14; C07D405/14; C07D409/14; C07D413/04; C07D413/10; C07D413/14; C07D417/14; C07D471/04; C07D487/04; C07D487/22	September 09, 2022
US20220283166A1	Application	METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS	A61P35/02; A61P35/04; C07K16/2896; G01N2333/70535; G01N2800/52; G01N33/57426; G01N33/57492	September 08, 2022
EP4051710A1	Application	ANTI-TUMOR-KOMBINATIONSTHERAPIE MIT ANTI-CD19-ANTIKÖRPERN UND GAMMA-DELTA-T-ZELLEN	A61K2039/505; A61K2300/00; A61K35/17; A61K39/395; A61P35/02; C07K16/2803; C07K2317/565; C07K2317/732	September 07, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Contact Us

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Contact Us

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer